Sumeet S Vaikunth, Juan M Ortega-Legaspi, Desiree R Conrad, Sharon Chen, Tami Daugherty, Christiane L Haeffele, Jeffrey Teuteberg, Rhondalynn Mclean, John W MacArthur, Y Joseph Woo, Katsuhide Maeda, Michael Ma, Teimour Nasirov, Marrouf Hoteit, Moira B Hilscher, Joyce Wald, Tal Mandelbaum, Kim M Olthoff, Peter L Abt, Pavan Atluri, Marisa Cevasco, Constantine D Mavroudis, Stephanie Fuller, George K Lui, Yuli Y Kim
INTRODUCTION: As the adult Fontan population with Fontan associated liver disease continues to increase, more patients are being referred for transplantation, including combined heart and liver transplantation. METHODS: We report updated mortality and morbidity outcomes after combined heart and liver transplant in a retrospective cohort series of 40 patients (age 14 to 49 years) with Fontan circulation across two centers from 2006-2022. RESULTS: The 30-day, 1-year, 5-year and 10-year survival rate was 90%, 80%, 73% and 73% respectively...
April 2024: Clinical Transplantation